Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is recognized as a leading third-party testing and analysis laboratory in the semiconductor industry, providing failure analysis, material analysis, and reliability analysis services, which are crucial for clients' R&D processes [4]. - In 2024, the company is projected to achieve revenue of 415 million yuan, with a compound annual growth rate (CAGR) of approximately 36% from 2020 to 2024 [4]. - The company has a strong focus on advanced process nodes, with revenue from advanced processes (28nm and below) increasing significantly over the years, indicating a growing market share [5]. - The semiconductor third-party testing and analysis market in China is expected to exceed 100 billion yuan by 2024, with a projected CAGR of over 10% until 2027 [6]. - The company is expanding its laboratory capabilities across multiple locations in China and has established a presence in Singapore to enhance its service offerings and collaboration with global semiconductor giants [6]. Financial Projections - The company is expected to generate revenues of 543 million yuan, 706 million yuan, and 919 million yuan in 2025, 2026, and 2027, respectively, with corresponding net profits of 110 million yuan, 161 million yuan, and 235 million yuan [8][10]. - The projected price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are 105, 72, and 49, respectively, indicating a favorable valuation trend as the company grows [8][10].